Inventors:
Huda Akil - Ann Arbor MI, US
Stanley Watson - Ann Arbor MI, US
Simon Evans - Milan MI, US
Cortney Turner - Ann Arbor MI, US
Rene Bernard - Ann Arbor MI, US
Ilan Kerman - Ann Arbor MI, US
Robert C. Thompson - Ann Arbor MI, US
Margit Burmeister - Ann Arbor MI, US
Laura J. Scott - Ann Arbor MI, US
Fan Meng - Ann Arbor MI, US
Michael Boehnke - Ann Arbor MI, US
William Bunney - Laguna Beach CA, US
Marquis Vawter - Laguna Niguel CA, US
Edward Jones - Winters CA, US
Prabhakara Choudary - Davis CA, US
Richard Myers - Stanford CA, US
Alan Schatzberg - Los Altos CA, US
Jun Li - Palo Alto CA, US
Devin Absher - San Francisco CA, US
Hiroaki Tomita - Irvine CA, US
International Classification:
A01K 67/00, C12Q 1/68, C12Q 1/02, G01N 33/68, A61K 38/17
US Classification:
800 8, 435 6, 435 29, 436 86, 514 12
Abstract:
The present application relates to the treatment and diagnosis of mood disorders, including bipolar disorder, major depression disorder and schizophrenia. The invention provides novel diagnostic markers and assays, as well as research tools for the development and discovery of agents and compounds which are useful for treating patients who suffer from mental illness.